Insulin Degludec
Products in Health Canada’s databases that list Insulin Degludec as a medicinal or active ingredient. Its salts and forms that the databases name on their own have their own pages.
- Drug products
- 4
- 3 authorized now
- Natural health products
- 0
- 0 active licences
- Notices of Compliance
- 11
- Products in all
- 4
Drug products
Authorized products first.
| Name | DIN | Status | Holder | Status since |
|---|---|---|---|---|
| TRESIBA (100 UNIT) | 02467860 | Marketed | Novo Nordisk Canada Inc | |
| TRESIBA (100 UNIT) | 02467879 | Marketed | Novo Nordisk Canada Inc | |
| TRESIBA (200 UNIT) | 02467887 | Marketed | Novo Nordisk Canada Inc | |
| XULTOPHY (100 UNIT) | 02474875 | Cancelled Post Market | Novo Nordisk Canada Inc |
Notices of Compliance
Approvals of drug submissions that list it, newest first.
- XULTOPHYAugust 21, 2025 · NOC 35874
- XULTOPHYDecember 2, 2024 · NOC 34529
- XULTOPHYApril 9, 2024 · NOC 33034
- XULTOPHYSeptember 15, 2023 · NOC 31646
- TRESIBAOctober 27, 2022 · NOC 29330
- TRESIBAJuly 23, 2021 · NOC 26325
- XULTOPHYNovember 13, 2020 · NOC 24603
- TRESIBAApril 17, 2019 · NOC 22071
- TRESIBA (FLEXTOUCH); TRESIBA (PENFILL)July 17, 2018 · NOC 21104
- XULTOPHYApril 11, 2018 · NOC 20731
- TRESIBA (FLEXTOUCH); TRESIBA (PENFILL)August 25, 2017 · NOC 19717